Synthesis, characterization, antiproliferative and anti-metastatic properties of two ruthenium-DMSO complexes containing 2,2′-biimidazole

European Journal of Medicinal Chemistry

Volumn 46, Issue 5, 2011, Pages 1555-1563

  Tan, Caiping ^a   Hu, Sheng ^c   Liu, Jie ^a,b   Ji, Liangnian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c GUANGDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

2,2 Biimidazole; Anti metastatic; Apoptosis; CDK inhibitors; Ruthenium complexes

Indexed keywords

CYCLIN DEPENDENT KINASE; DIMETHYL SULFOXIDE; RUTHENIUM COMPLEX;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL ADHESION; CELL CYCLE ARREST; CELL MIGRATION; CYTOTOXICITY; DRUG ACTIVITY; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; HUMAN CELL; X RAY ANALYSIS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL ADHESION; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CRYSTALLOGRAPHY, X-RAY; DIMETHYL SULFOXIDE; DRUG SCREENING ASSAYS, ANTITUMOR; HELA CELLS; HUMANS; IMIDAZOLES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; RUTHENIUM; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79953187971     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2011.01.074     Document Type: Article

References (57)

1. A. Alama, B. Tasso, F. Novelli, and F. Sparatore Organometallic compounds in oncology: implications of novel organotins as antitumor agents Drug Discov. Today 14 2009 500 508
2. A. Levina, A. Mitra, and P.A. Lay Recent developments in ruthenium anticancer drugs Metallomics 1 2009 458 470
3. E.S. Antonarakis, and A. Emadi Ruthenium-based chemotherapeutics: are they ready for prime time? Cancer Chemother. Pharmacol. 66 2010 1 9
4. J.M. Rademaker-Lakhai, D. van den Bongard, D. Pluim, J.H. Beijnen, and J.H. Schellens A Phase I and pharmacological study with imidazolium-trans-DMSO- imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent Clin. Cancer Res. 10 2004 3717 3727 (Pubitemid 38697605)
5. C.G. Hartinger, M.A. Jakupec, S. Zorbas-Seifried, M. Groessl, A. Egger, W. Berger, H. Zorbas, P.J. Dyson, and B.K. Keppler KP1019, a new redox-active anticancer agent-preclinical development and results of a clinical phase I study in tumor patients Chem. Biodivers. 5 2008 2140 2155
6. L. Bratsos, S. Jedner, T. Gianferrara, and E. Alessio Ruthenium anticancer compounds: challenges and expectations Chimia 61 2007 692 697
7. C.G. Hartinger, S. Zorbas-Seifried, M.A. Jakupec, B. Kynast, H. Zorbas, and B.K. Keppler From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H- indazole)ruthenate(III)] (KP1019 or FFC14A) J. Inorg. Biochem. 100 2006 891 904 (Pubitemid 44308176)
8. T. Bando, H. Iida, Z.F. Tao, A. Narita, N. Fukuda, T. Yamori, and H. Sugiyama Sequence specificity, reactivity, and antitumor activity of DNA-alkylating pyrrole-imidazole diamides Chem. Biol. 10 2003 751 758 (Pubitemid 37089850)
9. W.T. Li, D.R. Hwang, J.S. Song, C.P. Chen, J.J. Chuu, C.B. Hu, H.L. Lin, C.L. Huang, C.Y. Huang, H.Y. Tseng, C.C. Lin, T.W. Chen, C.H. Lin, H.S. Wang, C.C. Shen, C.M. Chang, Y.S. Chao, and C.T. Chen Synthesis and biological activities of 2-amino-1-arylidenamino imidazoles as orally active anticancer agents J. Med. Chem. 53 2010 2409 2417
10. D.C. Kennedy, and B.R. James Syntheses of ruthenium (II)-4,4-biimidazole complexes and their potential anti-tumour activity Can. J. Chem. 88 2010 886 892
11. L. Ion, D. Morales, J. Perez, L. Riera, V. Riera, R.A. Kowenicki, and M. McPartlin Ruthenium biimidazole complexes as anion receptors Chem. Commun. 2006 91 93
12. Y. Cui, H.J. Mo, J.C. Chen, Y.L. Niu, Y.R. Zhong, K.C. Zheng, and B.H. Ye Anion-selective interaction and colorimeter by an optical metalloreceptor based on ruthenium(II) 2,2'-biimidazole: hydrogen bonding and proton transfer Inorg. Chem. 46 2007 6427 6436
13. S. Derossi, H. Adams, and M.D. Ward Hydrogen-bonded assemblies of ruthenium(II)-biimidazole complex cations and cyanometallate anions: structures and photophysics Dalton Trans. 2007 33 36 (Pubitemid 44907698)
14. M. Tadokoro, T. Inoue, S. Tamaki, K. Fujii, K. Isogai, H. Nakazawa, S. Takeda, K. Isobe, N. Koga, A. Ichimura, and K. Nakasuji Mixed-valence states stabilized by proton transfer in a hydrogen-bonded biimidazolate rhenium dimer Angew. Chem., Int. Ed. 46 2007 5938 5942 (Pubitemid 47236475)
15. 2O J. Phys. Chem. B. 113 2009 14323 14328
16. R. Indumathy, T. Weyhermuller, and B.U. Nair Biimidazole containing cobalt(III) mixed ligand complexes: crystal structure and photonuclease activity Dalton Trans. 39 2010 2087 2097
17. C.P. Tan, J. Liu, L.M. Chen, S. Shi, and L.N. Ji Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes J. Inorg. Biochem. 102 2008 1644 1653
18. E. Alessio Synthesis and reactivity of Ru-, Os-, Rh-, and Ir-halide-sulfoxide complexes Chem. Rev. 104 2004 4203 4242
19. C. Sens, M. Rodriguez, I. Romero, A. Llobet, T. Parella, B.P. Sullivan, and J. Benet-Buchholz Synthesis, structure, and spectroscopic, photochemical, redox, and catalytic properties of ruthenium(II) isomeric complexes containing dimethyl sulfoxide, chloro, and the dinucleating bis(2-pyridyl)pyrazole ligands Inorg. Chem. 42 2003 2040 2048
20. 3(dmso)(tmen)]. Dimethylsulfoxide is sulfur-bonded to Ru(II), Ru(III), and Ru(IV) Inorg. Chem. 38 1999 2 3
21. R.C. van der Drift, J.W. Sprengers, E. Bouwman, W.P. Mul, H. Kooijman, A.L. Spek, and E. Drent Ruthenium-catalyzed isomerization of allylic alcohols: oxidation state determines resistance against diene inhibition Eur. J. Inorg. Chem. 2002 2147 2155
22. 3(TMSO)(bpy)] complexes Polyhedron 26 2007 5389 5397
23. 2], (PMRu52), a novel ruthenium(II) compound acting as a strong inhibitor of cathepsin B J. Inorg. Biochem. 104 2010 111 117
24. M.B. Cingi, M. Lanfranchi, M.A. Pellinghelli, and M. Tegoni Synthesis, spectroscopic and structural characterization of new Ru-II and Ru-III complexes containing triazole- and thiadiazole-type ligands Eur. J. Inorg. Chem. 2000 703 711
25. M. Calligaris Structure and bonding in metal sulfoxide complexes: an update Coord. Chem. Rev. 248 2004 351 375
26. m, n/m=2/+, 1/0, 0/-. Synthesis, structures, solution properties and anion receptor features in solution state Dalton Trans. 39 2010 4232 4242
27. 2] investigated by means of HPCE and HPLC-MS J. Biol. Inorg. Chem. 6 2001 292 299 (Pubitemid 32823962)
28. M. Groessl, C.G. Hartinger, P.J. Dyson, and B.K. Keppler CZE-ICP-MS as a tool for studying the hydrolysis of ruthenium anticancer drug candidates and their reactivity towards the DNA model compound dGMP J. Inorg. Biochem. 102 2008 1060 1065
29. M. Bacac, A.C.G. Hotze, K. van der Schilden, J.G. Haasnoot, S. Pacor, E. Alessio, G. Sava, and J. Reedijk The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation J. Inorg. Biochem. 98 2004 402 412 (Pubitemid 38083159)
30. 2-M cell fraction and inhibition of Matrigel invasion, may predict in vivo-selective antimetastasis activity of ruthenium complexes J. Pharmacol. Exp. Ther. 295 2000 927 933
31. A. Bergamo, and G. Sava Ruthenium complexes can target determinants of tumour malignancy Dalton Trans. 2007 1267 1272 (Pubitemid 46449547)
32. I. Kostova Ruthenium complexes as anticancer agents Curr. Med. Chem. 13 2006 1085 1107
33. M.A. Hotz, J. Gong, F. Traganos, and Z. Darzynkiewicz Flow cytometric detection of apoptosis: comparison of the assays of in situ DNA degradation and chromatin changes Cytometry 15 1994 237 244
34. R.C. Taylor, S.P. Cullen, and S.J. Martin Apoptosis: controlled demolition at the cellular level Nat. Rev. Mol. Cell Biol. 9 2008 231 241 (Pubitemid 351301823)
35. R.S. Hotchkiss, A. Strasser, J.E. McDunn, and P.E. Swanson Cell death N. Engl. J. Med. 361 2009 1570 1583
36. S. Kapitza, M. Pongratz, M.A. Jakupec, P. Heffeter, W. Berger, L. Lackinger, B.K. Keppler, and B. Marian Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells J. Cancer Res. Clin. Oncol. 131 2005 101 110 (Pubitemid 40192935)
37. S. Kapitza, M.A. Jakupec, M. Uhl, B.K. Keppler, and B. Marian The heterocyclic ruthenium(III) complex KP1019 (FFC14A) causes DNA damage and oxidative stress in colorectal tumor cells Cancer Lett. 226 2005 115 121 (Pubitemid 41039079)
38. S. Chatterjee, S. Kundu, A. Bhattacharyya, C.G. Hartinger, and P.J. Dyson The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways J. Biol. Inorg. Chem. 13 2008 1149 1155
39. E. Meggers, G.E. Atilla-Gokcumen, K. Grundler, C. Frias, and A. Prokop Inert ruthenium half-sandwich complexes with anticancer activity Dalton Trans. 2009 10882 10888
40. X.J. Liang, Y. Choi, D.L. Sackett, and J.K. Park Nitrosoureas inhibit the stathmin-mediated migration and invasion of malignant glioma cells Cancer Res. 68 2008 5267 5272
41. M.M. Liu, Z.J. Lim, Y.Y. Gwee, A. Levina, and P.A. Lay Characterization of a ruthenium(III)/NAMI-A adduct with bovine serum albumin that exhibits a high anti-metastatic activity Angew. Chem. Int. Ed. 49 2010 1661 1664
42. Y. Chen, B. Lu, Q. Yang, C. Fearns, J.R. Yates, and J.D. Lee Combined integrin phosphoproteomic analyses and small interfering RNA-based functional screening identify key regulators for cancer cell adhesion and migration Cancer Res. 69 2009 3713 3720
43. C. Gossens, I. Tavernelli, and U. Rothlisberger DNA structural distortions induced by ruthenium-arene anticancer compounds J. Am. Chem. Soc. 130 2008 10921 10928
44. V. Rajendiran, M. Murali, E. Suresh, S. Sinha, K. Somasundaram, and M. Palaniandavar Mixed ligand ruthenium(II) complexes of bis(pyrid-2-yl)-/ bis(benzimidazol-2-yl)-dithioether and diimines: study of non-covalent DNA binding and cytotoxicity Dalton Trans. 2008 148 163 (Pubitemid 350264918)
45. V. Rajendiran, M. Murali, E. Suresh, M. Palaniandavar, V.S. Periasamy, and M.A. Akbarsha Non-covalent DNA binding and cytotoxicity of certain mixed-ligand ruthenium(II) complexes of 2,2'-dipyridylamine and diimines Dalton Trans. 2008 2157 2170 (Pubitemid 351503481)
46. M. Malumbres, and M. Barbacid Mammalian cyclin-dependent kinases Trends Biochem. Sci. 30 2005 630 641 (Pubitemid 41540083)
47. M. Malumbres, and M. Barbacid Cell cycle kinases in cancer Curr. Opin. Genet. Dev. 17 2007 60 65 (Pubitemid 46109297)
48. W.M. Stadler, N.J. Vogelzang, R. Amato, J. Sosman, D. Taber, D. Liebowitz, and E.E. Vokes Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a university of Chicago phase II consortium study J. Clin. Oncol. 18 2000 371 375 (Pubitemid 30056427)
49. J.C. Xiao, and J.M. Shreeve Synthesis of 2,2'-biimidazolium-based Ionic liquids: use as a new reaction medium and ligand for palladium-catalyzed suzuki cross-coupling reactions J. Org. Chem. 70 2005 3072 3078 (Pubitemid 40547527)
50. I. Evans, A. Spencer, and G. Wilkinson Dichlorotetrakis (dimethyl sulphoxide) ruthenium (II) and its use as a source material for some new ruthenium (II) complexes Dalton Trans. 1973 204 209
51. E. Alessio, G. Balducci, M. Calligaris, G. Costa, W.M. Attia, and G. Mestroni Synthesis, molecular structure, and chemical behavior of hydrogen trans-bis(dimethyl sulfoxide)tetrachlororuthenate(III) and mer- trichlorotris(dimethyl sulfoxide)ruthenium(III): the first fully characterized chloride-dimethyl sulfoxide-ruthenium(III) complexes Inorg. Chem. 30 1991 609 618
52. B.K. Keppler, W. Rupp, U.M. Juhl, H. Endres, R. Niebl, and W. Balzer Synthesis, molecular structure, and tumor-inhibiting properties of imidazolium trans-bis(imidazole)tetrachlororuthenate(III) and its methyl-substituted derivatives Inorg. Chem. 26 1987 4366 4370
53. G. Mestroni, E. Alessio, G. Sava, New salt of anionic complexes of Ru (III) as antimetastatic and antineoplastic agents, PCT Int. Appl. WO/1998/000431 (1998).
54. G. Sheldrick SADABS, Program for Empirical Absorption Correction of Area Detector Data 1996 University of Göttingen Germany
55. G. Sheldrick SHELXL97, a Computer Program for Crystal Structure Determination 1997 University of Göttingen Germany
56. C.P. Tan, J. Liu, H. Li, W.J. Zheng, S. Shi, L.M. Chen, and L.N. Ji Differences in structure, physiological stability, electrochemistry, cytotoxicity, DNA and protein binding properties between two Ru(III) complexes J. Inorg. Biochem. 102 2008 347 358
57. C.C. Liang, A.Y. Park, and J.L. Guan In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro Nat. Protoc. 2 2007 329 333 (Pubitemid 47040047)